title: Lipid and low-density-lipoprotein apheresis. Effects on plasma inflammatory profile and on cytokine pattern in patients with severe dyslipidemia.
abstract: Available evidence on the effects of therapeutic plasmapheresis (TP) techniques and in particular lipid- and LDL-apheresis (LDL-a) on plasmatic inflammatory mediators including cytokines were reviewed. Studies on this issue are not numerous. However, the review of existing evidence clearly suggests an active role of apheresis on the profile of inflammatory molecules and on cytokine pattern in plasma. These non-lipid-lowering effects can be defined to some extent pleiotropic or pleiotropic-equivalent. Although further studies are desirable, the data reported in this review confirm that lipid- and LDL-a not only show acute lipid-lowering and cholesterol-lowering effects, but also efficacy in reducing several proinflammatory peptides, including cytokines. This effect was not related apparently to lipids and lipoproteins reduction. Thus, TP (lipid- and LDL-a), commonly utilized in the treatment of severe genetically determined lipid disorders, unresponsive to hypolipidemic drugs, offers new possibilities of interpretation of its role in the mechanisms leading to the blockade of atherosclerotic lesion development and progression. The ability of TP on short-term to induce such a profound change in the plasmatic metabolic and inflammatory profiles must be kept in mind in the treatment of acute coronary syndromes, before and after interventions of coronary revascularization, and in the acute phase of cerebrovascular ischemia, at least in patients with severe dyslipidemia. Further studies are needed, in particular aimed at assessing if circulating cytokines may be downregulated by TP not only by direct removal, but through indirect effects on both gene translation and transcription perhaps via the cytokine receptor function.
authors.affiliation: Extracorporeal Therapeutic Techniques Unit-Immunohematology and Transfusion Medicine, Department of Molecular Medicine, La Sapienza University of Rome, Italy. cstefanutti@alice.it
authors.forename: Claudia
authors.initials: C
authors.lastname: Stefanutti
authors.forename: Claudia
authors.initials: C
authors.lastname: Morozzi
authors.forename: Andrea
authors.initials: A
authors.lastname: Petta
mesh_terms: D001781:Blood Component Removal; D016207:Cytokines / Q000097:blood; D050171:Dyslipidemias / Q000097:blood* / Q000473:pathology*; D006801:Humans; D007249:Inflammation / Q000097:blood*; D008077:Lipoproteins, LDL / Q000302:isolation & purification*
chemical_list: D016207:Cytokines; D008077:Lipoproteins, LDL